BYSI
Price
$2.20
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
29 days until earnings call
CYTK
Price
$52.26
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
8 days until earnings call
Ad is loading...

BYSI vs CYTK

Header iconBYSI vs CYTK Comparison
Open Charts BYSI vs CYTKBanner chart's image
BeyondSpring
Price$2.20
Change-$0.00 (-0.00%)
Volume$41.97K
CapitalizationN/A
Cytokinetics
Price$52.26
Change-$0.00 (-0.00%)
Volume$760.97K
CapitalizationN/A
View a ticker or compare two or three
BYSI vs CYTK Comparison Chart
Loading...
BYSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BYSI vs. CYTK commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BYSI is a StrongBuy and CYTK is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (BYSI: $2.20 vs. CYTK: $52.26)
Brand notoriety: BYSI and CYTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BYSI: 148% vs. CYTK: 67%
Market capitalization -- BYSI: $92.29M vs. CYTK: $6.16B
BYSI [@Biotechnology] is valued at $92.29M. CYTK’s [@Biotechnology] market capitalization is $6.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BYSI’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • BYSI’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than BYSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BYSI’s TA Score shows that 5 TA indicator(s) are bullish while CYTK’s TA Score has 3 bullish TA indicator(s).

  • BYSI’s TA Score: 5 bullish, 3 bearish.
  • CYTK’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BYSI is a better buy in the short-term than CYTK.

Price Growth

BYSI (@Biotechnology) experienced а -5.58% price change this week, while CYTK (@Biotechnology) price change was -2.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BYSI is expected to report earnings on Nov 27, 2024.

CYTK is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($6.16B) has a higher market cap than BYSI($92.3M). BYSI YTD gains are higher at: 144.444 vs. CYTK (-37.406). BYSI has higher annual earnings (EBITDA): -15.78M vs. CYTK (-459.67M). CYTK has more cash in the bank: 1.06B vs. BYSI (14.4M). BYSI has less debt than CYTK: BYSI (3.69M) vs CYTK (790M). CYTK has higher revenues than BYSI: CYTK (3.13M) vs BYSI (1.88M).
BYSICYTKBYSI / CYTK
Capitalization92.3M6.16B1%
EBITDA-15.78M-459.67M3%
Gain YTD144.444-37.406-386%
P/E RatioN/AN/A-
Revenue1.88M3.13M60%
Total Cash14.4M1.06B1%
Total Debt3.69M790M0%
FUNDAMENTALS RATINGS
BYSI vs CYTK: Fundamental Ratings
BYSI
CYTK
OUTLOOK RATING
1..100
7871
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10046
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3958
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BYSI's Valuation (63) in the Pharmaceuticals Major industry is somewhat better than the same rating for CYTK (100) in the Biotechnology industry. This means that BYSI’s stock grew somewhat faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (46) in the Biotechnology industry is somewhat better than the same rating for BYSI (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew somewhat faster than BYSI’s over the last 12 months.

BYSI's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as CYTK (100) in the Biotechnology industry. This means that BYSI’s stock grew similarly to CYTK’s over the last 12 months.

BYSI's Price Growth Rating (39) in the Pharmaceuticals Major industry is in the same range as CYTK (58) in the Biotechnology industry. This means that BYSI’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for BYSI (100) in the Pharmaceuticals Major industry. This means that CYTK’s stock grew significantly faster than BYSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BYSICYTK
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BYSI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

BYSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BYSI has been loosely correlated with GOSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BYSI jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BYSI
1D Price
Change %
BYSI100%
-2.65%
GOSS - BYSI
38%
Loosely correlated
-2.00%
CYTK - BYSI
37%
Loosely correlated
+1.83%
VNDA - BYSI
33%
Poorly correlated
+5.05%
RCUS - BYSI
31%
Poorly correlated
+2.08%
MTNB - BYSI
29%
Poorly correlated
-1.54%
More

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with KRON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then KRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+1.83%
KRON - CYTK
43%
Loosely correlated
+0.94%
IOVA - CYTK
42%
Loosely correlated
+3.47%
DARE - CYTK
42%
Loosely correlated
+7.67%
CKPT - CYTK
41%
Loosely correlated
+0.27%
DSGN - CYTK
40%
Loosely correlated
+1.65%
More